3 top growth shares I would buy in July

A2 Milk Company Ltd (ASX:A2M) and two other growth shares are on my shopping list this month…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This week marks the start of a new financial year for investors, which I think is a great time to look at new additions to portfolios.

If you're a fan of growth shares then the three listed below could be worth a look in FY 2019. Each delivered strong returns for their respective shareholders in the last financial year and I expect more of the same this time around,

Here's why I like them:

A2 Milk Company Ltd (ASX: A2M)

This infant formula and dairy company may have lost a bit of its shine over the last few weeks after its full-year sales guidance came in a little softer than expected, but there's no denying that there is incredible demand for its premium products in China. So much so, some supermarkets have had to put its infant formula out of reach behind the counter. I believe a2 Milk is perfectly positioned to capture this demand and deliver earnings growth that justifies the lofty earnings multiple its shares trade on.

Aristocrat Leisure Limited (ASX: ALL)

This gaming technology company remains my favourite growth share on the Australian share market for a number of reasons. These include its reasonable valuation for its current growth profile, its fast-growing digital segment, and the sizeable recurring revenues this segment produces. And with the company generating a significant amount of its revenue in the United States, it could benefit greatly if the Australian dollar continues to weaken. Overall, I feel Aristocrat Leisure could grow earnings at an above-average rate for the next few years at least.

CSL Limited (ASX: CSL)

Another top growth share that I would buy today is this biotherapeutics company. Although it has provided stellar returns for its shareholders over the last 12 months, one leading broker doesn't think it is too late to invest. Yesterday Goldman Sachs initiated coverage on CSL with a buy rating and $231.00 price target. I agree with this view and think it is destined to deliver strong profit growth for the foreseeable future thanks to the quality of its core operations, its strong pipeline of new products in development, and the success of its fledgling influenza business.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »